Trastuzumab,Tucatinib
Seagen,Roche
[]
exciting day 1 at #gi23 and a new drug approval to boot! tucatinib approved for her2+ met crc based on mountaineer. much needed on label option for crc. 
GI medical oncologist at Saint Luke’s Cancer Institute in KCMO. Husband, father, dog dad, Chiefs fan, KU & Vandy alum. Tweets are my own.